GlobalData on MSN17h
FibroGen sells China unit to AstraZeneca for $160mAstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback